NCT03880591View on ClinicalTrials.gov

Neonatal Hyperbilirubinaemia in the Democratic Republic of Congo

CompletedOBSERVATIONAL
Enrollment

306

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

December 3, 2020

Study Completion Date

December 10, 2020

Conditions
Neonatal Hyperbilirubinemia
Trial Locations (1)

Unknown

Kinshasa Medical Oxford Research Unit, Kinsasa

All Listed Sponsors
collaborator

Kinshasa School of Public Health

OTHER

lead

University of Oxford

OTHER

NCT03880591 - Neonatal Hyperbilirubinaemia in the Democratic Republic of Congo | Biotech Hunter | Biotech Hunter